Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Ever since Medicare proposed to sharply limit coverage of the controversial Alzheimer’s drug Aduhelm, the agency ...
Read moreEver since Medicare proposed to sharply limit coverage of the controversial Alzheimer’s drug Aduhelm, the agency ...
Read moreBEIJING (AP) — A two-phase lockdown of Shanghai’s 26 million people is testing the limits of ...
Read moreThe Omicron variant of the coronavirus comes at a challenging moment for the Federal Reserve, as ...
Read moreThe new Covid-19 variant has been wobbling financial markets and may continue to do so temporarily.The new ...
Read more© 2022 TheDailyStock.News